Basit öğe kaydını göster

dc.contributor.authorBadur, İsa
dc.contributor.authorBilgin Badur, Naciye
dc.contributor.authorBerk, Barkın
dc.date.accessioned2022-11-30T07:44:17Z
dc.date.available2022-11-30T07:44:17Z
dc.date.issued2022en_US
dc.identifier.citationBadur, İ., Bilgin Badur, N. ve Berk, B. (2022). Investigation of hidden crisis of prescription drug abuse in Turkey: Pregabalin monitoring. Acta Pharmaceutica Sciencia, 60(4), 313-323. https://doi.org/10.23893/1307-2080.APS6021en_US
dc.identifier.issn1307-2080
dc.identifier.urihttps://doi.org/10.23893/1307-2080.APS6021
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10046
dc.description.abstractThis is a cross-sectional retrospective observational national study. Abuse/misuse of the pregabalin and related parameters analyzed. Pregabalin was mostly pre-scribed by general practitioners (26.2%). Pregabalin prescribing frequencies of other physicians were as follows, respectively: neurology (14.1%); mental health and illness (12%); physical therapy and rehabilitation (8.8%); internal medicine (4.8%). Accordingly, pregabalin (811.954box) and paracetamol, combinations excl. psycholeptics (1,131,069box) were the first two sales. In total cost of sales, pre-gabalin (57,721,322.00 TL) and methylphenidate (41,915,196.00 TL) were the top two sales rankings. According to the disposal results of ILAYS pharmaceuticals in 2020, pregabalin (2693box per year) and morphine (862box per year) were the most disposed drugs. It was determined that the frequency of pregabalin was fol-lowed by gabapentin. In conclusion, our study reveals the extent of abuse of prega-balin in Turkey with its data.en_US
dc.language.isoengen_US
dc.publisherIstanbul Medipol Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectControlled Drug Pharmaco-Economyen_US
dc.subjectDrug Abuseen_US
dc.subjectPregabalinen_US
dc.subjectPrescription Drug Monitoringen_US
dc.titleInvestigation of hidden crisis of prescription drug abuse in Turkey: Pregabalin monitoringen_US
dc.typearticleen_US
dc.relation.ispartofActa Pharmaceutica Scienciaen_US
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Enstitüsü, Sinirbilim Ana Bilim Dalıen_US
dc.authorid0000-0002-0306-4259en_US
dc.authorid0000-0001-6577-0100en_US
dc.authorid0000-0001-6047-2796en_US
dc.identifier.volume60en_US
dc.identifier.issue4en_US
dc.identifier.startpage313en_US
dc.identifier.endpage323en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.23893/1307-2080.APS6021en_US
dc.institutionauthorBadur, İsa
dc.institutionauthorBilgin Badur, Naciye
dc.institutionauthorBerk, Barkın
dc.identifier.scopus2-s2.0-85141390615en_US
dc.identifier.scopusqualityQ3en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster